Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Price / Earnings (ltm)

Arbutus Biopharma Cp Price / Earnings (ltm) Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Price / Earnings (ltm) from 2013 to 2013. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Arbutus Biopharma Cp Price / Earnings (ltm) for the quarter ending December 12, 2013 was 4.62 a 51.18% increase of 2.37 year over year
Other Valuation Metrics:
  • Arbutus Biopharma Cp Market Cap for the quarter ending March 03, 2018 was $275m a 28.06% increase of 77m year over year
  • Arbutus Biopharma Cp Price / Book for the quarter ending March 03, 2018 was 2.07 a 49.51% increase of 1.03 year over year
  • Arbutus Biopharma Cp Enterprise Value for the quarter ending March 03, 2018 was $211m a 52.69% increase of 111m year over year
View Chart On Koyfin

Quarterly ABUS Price / Earnings (ltm) Data

12/20134.62
09/20133.72
06/20132.31
03/20132.26

Annual ABUS Price / Earnings (ltm) Data

20134.62